Evidence map›Paper›PMID 19286625›Full record

ArticleAmerican journal of respiratory and critical care medicine2009

Repeated aerosol delivery of carboxyl-terminal modulator protein suppresses tumor in the lungs of K-rasLA1 mice.

Soon-Kyung Hwang, Hwang-Tae Lim, Arash Minai-Tehrani, Eun-Sun Lee, Jongmin Park, Seung Bum Park, George R Beck, Myung-Haing Cho

Open access · greenAbstract readComparative Study
In one paragraph

Article in American journal of respiratory and critical care medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Roles of THEM4 in the Akt pathway: a double-edged sword.Journal of Zhejiang University. Science. B · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Soon-Kyung HwangLaboratory of Toxicology, College of Veterinary Medicine, Seoul National University, Seoul, Korea.
Hwang-Tae Lim
Arash Minai-Tehrani
Eun-Sun Lee
Jongmin Park
Seung Bum Park
George R Beck
Myung-Haing Cho
Seoul National University · KRCore Research Center

Funding

Biological Actions and Cellular Targeting of Nanoparticles for Medical ApplicatioR01AR056090 · NIAMS · EMORY UNIVERSITY · PI BECK, GEORGE R., WEITZMANN, MERVYN NEALE · 2008 to 2010
$984k
BLRD VA I01 BX000105NIAMS NIH HHS R01 AR056090
6 · The paper itself

Abstract

rationaleDifficulties in achieving long-term survival of patients with lung cancer treated with conventional therapies suggest that novel approaches are required. Recent advances in aerosol-mediated gene delivery have provided the possibility of an alternative for the safe and effective treatment of lung cancer.

objectivesTo investigate the repeated effect of carboxyl-terminal modulator protein (CTMP) on multistage lung tumorigenesis. In this study, we addressed this question by studying the effects of lentivirus-based CTMP in the lungs of 9- and 13-week-old K-ras(LA1) mice, a model of lung cancer.

methodsAn aerosol of lentivirus-based CTMP was delivered into 9- and 13-week-old K-ras(LA1) mice, a model of lung cancer, through a nose-only inhalation system twice a week for 4 weeks. The effects of CTMP on lung cancer progression and Akt-related signals were evaluated. MEASUREMENTS AND MAIN

resultsLong-term repeated delivery of CTMP effectively reduced tumor progression in the lungs at different stages of development. Lentiviral-CTMP inhibited protein synthesis and cell cycle and altered Akt signaling pathway in the lungs of 9-week-old K-ras(LA1) mice, and increased apoptosis was observed in the lungs of 13-week-old K-ras(LA1) mice.

conclusionsLong-term repeated viral delivery of CTMP may provide a useful tool for designing lung tumor treatment.

Indexed as

Gene Expression Regulation, NeoplasticGene Transfer TechniquesAdenocarcinomaAerosolsAnimalsApoptosisBlotting, WesternCarrier ProteinsCell Line, TumorDisease ProgressionGenes, rasIn Situ Nick-End LabelingLung NeoplasmsMaleMiceMice, Inbred C57BLAerosolsCarrier ProteinsCTMP protein, mousePalmitoyl-CoA Hydrolase

Identifiers

PMID19286625
PMCPMC5450614
OpenAlexW2120539211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.